In summary, we established links between abnormal marker expression and GBM disruptions in both primary and secondary glomerular diseases, highlighting the pivotal roles of COL4A3/4/5 and Laminin α5β2γ1 in influencing GBM thickness, alongside perturbations in Integrin α3β1. The gene discussed is COL4A3; the disease is glomerular disorder.